Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  119,822 results for ""Factor IX""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B-LONG study.

  • Authors : Nolan B; Haematology Department, Children's Health Ireland at Crumlin, Dublin, Republic of Ireland.; Recht M

Subjects: Factor IX*/Factor IX*/Factor IX*/administration & dosage ; Factor IX*/Factor IX*/Factor IX*/therapeutic use ; Hemophilia B*/Hemophilia B*/Hemophilia B*/drug therapy

  • Source: European journal of haematology [Eur J Haematol] 2024 Oct; Vol. 113 (4), pp. 485-492. Date of Electronic Publication: 2024 Jun 25.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read More Add to Saved list
×
Academic Journal

Transplacental delivery of factor IX Fc-fusion protein ameliorates bleeding phenotype of newborn hemophilia B mice.

  • Authors : Sakurai F; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan. Electronic address: .; Iizuka S

Subjects: Factor IX*/Factor IX*/Factor IX*/administration & dosage ; Factor IX*/Factor IX*/Factor IX*/genetics ; Hemophilia B*/Hemophilia B*/Hemophilia B*/therapy

  • Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Oct; Vol. 374, pp. 415-424. Date of Electronic Publication: 2024 Aug 24.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Characterization of recombinant factor IX fusion proteins enabling subcutaneous administration.

  • Authors : Schön K; Pharmacology & Toxicology, Research, CSL Innovation GmbH, Marburg, Hesse, Germany; Institute of Pharmacology, Biochemical-Pharmacological Center, University of Marburg, Marburg, Hesse, Germany.

Subjects: Factor IX*/Factor IX*/Factor IX*/pharmacokinetics ; Factor IX*/Factor IX*/Factor IX*/genetics ; Factor IX*/Factor IX*/Factor IX*/administration & dosage

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Oct; Vol. 22 (10), pp. 2713-2723. Date of Electronic Publication: 2024 Jul 15.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

Read More Add to Saved list
×
Academic Journal

PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space.

Subjects: Collagen Type IV*/Collagen Type IV*/Collagen Type IV*/pharmacokinetics ; Collagen Type IV*/Collagen Type IV*/Collagen Type IV*/metabolism ; Collagen Type IV*/Collagen Type IV*/Collagen Type IV*/administration & dosage

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Oct; Vol. 13 (10), pp. 1630-1640. Date of Electronic Publication: 2024 Sep 16.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Blood coagulation factor IX: structural insights impacting hemophilia B therapy.

  • Authors : Bos MHA; Department of Internal Medicine, Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.; van Diest RE

Subjects: Hemophilia B*/Hemophilia B*/Hemophilia B*/therapy ; Hemophilia B*/Hemophilia B*/Hemophilia B*/genetics ; Hemophilia B*/Hemophilia B*/Hemophilia B*/metabolism

  • Source: Blood [Blood] 2024 Nov 21; Vol. 144 (21), pp. 2198-2210.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

Read More Add to Saved list
×
Academic Journal

A novel snake venom C-type lectin-like protein modulates blood coagulation by targeting von Willebrand factor and coagulation factor IX.

  • Authors : Zeng FY; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China.; School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, China.

Subjects: von Willebrand Factor*/von Willebrand Factor*/von Willebrand Factor*/metabolism ; Blood Coagulation*/Blood Coagulation*/Blood Coagulation*/drug effects ; Lectins, C-Type*/Lectins, C-Type*/Lectins, C-Type*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 Oct 03; Vol. 14 (1), pp. 22962. Date of Electronic Publication: 2024 Oct 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Assessing health care resource use, outcomes, and costs among Medicaid beneficiaries receiving factor IX prophylaxis for hemophilia B.

  • Authors : Pauly N; Manatt Health Strategies, LLC, New York City, NY.; Burrell A

Subjects: Hemophilia B*/Hemophilia B*/Hemophilia B*/drug therapy ; Hemophilia B*/Hemophilia B*/Hemophilia B*/economics ; Medicaid*/Medicaid*/Medicaid*/economics

  • Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Oct; Vol. 30 (10), pp. 1095-1105. Date of Electronic Publication: 2024 Jun 26.Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec.

  • Authors : Pittman DD; Rare Disease Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States.; Carrieri C

Subjects: Factor IX*/Factor IX*/Factor IX*/genetics ; Factor IX*/Factor IX*/Factor IX*/metabolism ; Factor IX*/Factor IX*/Factor IX*/therapeutic use

  • Source: Thrombosis and haemostasis [Thromb Haemost] 2024 Oct; Vol. 124 (10), pp. 912-921. Date of Electronic Publication: 2024 Jun 11.Publisher: Thieme Country of Publication: Germany NLM ID: 7608063 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-689X

Record details

Read More Add to Saved list
×
Academic Journal

An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B.

  • Authors : Sacco M; Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Rome, Italy.; Testa MF

Subjects: Factor IX*/Factor IX*/Factor IX*/genetics ; Factor IX*/Factor IX*/Factor IX*/metabolism ; Hemophilia B*/Hemophilia B*/Hemophilia B*/genetics

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Oct; Vol. 22 (10), pp. 2724-2738. Date of Electronic Publication: 2024 Jul 15.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

Read More Add to Saved list
×
Academic Journal

Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors.

  • Authors : Shu M; Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.; Malcolmson C

Subjects: Hemophilia B*/Hemophilia B*/Hemophilia B*/blood ; Hemophilia B*/Hemophilia B*/Hemophilia B*/diagnosis ; Hemophilia B*/Hemophilia B*/Hemophilia B*/genetics

  • Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2024 Jul; Vol. 30 (4), pp. 1003-1009. Date of Electronic Publication: 2024 Jun 24.Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  119,822 results for ""Factor IX""